Jardiance (empagliflozin) is a prescription drug that’s used to manage blood sugar levels and lower certain risks. The drug comes as an oral tablet. It’s usually taken once per day.

Jardiance costs $41 per month with Medicare on average. People who earn a low income and qualify for government help will pay less than $2 per month for Jardiance on average. You need a Medicare Part ...

Boehringer Ingelheim and Eli Lilly have received the Food and Drug Administration's green light for Jardiance (empagliflozin) 10 mg tablets to reduce the risk of sustained decline in estimated ...

The Food and Drug Administration approved Eli Lilly’s Jardiance (empagliflozin) for treating adults with chronic kidney disease (CKD) on Friday morning. The agency approved 10 mg tablets of Jardiance ...

Jardiance had a 28% relative risk reduction for kidney disease progression vs. placebo. The drug also showed a significant reduction in hospitalization risk in patients with CKD. The FDA approved ...